A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting
Open Access
- 20 April 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in npj Vaccines
- Vol. 3 (1), 14
- https://doi.org/10.1038/s41541-018-0052-x
Abstract
Rift Valley fever virus, a phlebovirus endemic in Africa, causes serious diseases in ruminants and humans. Due to the high probability of new outbreaks and spread to other continents where competent vectors are present, vaccine development is an urgent priority as no licensed vaccines are available outside areas of endemicity. In this study, we evaluated in sheep the protective immunity induced by DNA vaccines encoding the extracellular portion of the Gn antigen which was either or not targeted to antigen-presenting cells. The DNA encoding untargeted antigen was the most potent at inducing IgG responses, although not neutralizing, and conferred a significant clinical and virological protection upon infectious challenge, superior to DNA vaccines encoding the targeted antigen. A statistical analysis of the challenge parameters supported that the anti-eGn IgG, rather than the T-cell response, was instrumental in protection. Altogether, this work shows that a DNA vaccine encoding the extracellular portion of the Gn antigen confers substantial—although incomplete—protective immunity in sheep, a natural host with high preclinical relevance, and provides some insights into key immune correlates useful for further vaccine improvements against the Rift Valley fever virus.Keywords
This publication has 61 references indexed in Scilit:
- DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in miceBMC Immunology, 2013
- A Single Immunization with MVA Expressing GnGc Glycoproteins Promotes Epitope-specific CD8+-T Cell Activation and Protects Immune-competent Mice against a Lethal RVFV InfectionPLoS Neglected Tropical Diseases, 2013
- Immunogenicity of DNA Vaccines Encoding Simian Immunodeficiency Virus Antigen Targeted to Dendritic Cells in Rhesus MacaquesPLOS ONE, 2012
- Skin Langerin+ Dendritic Cells Transport Intradermally Injected Anti–DEC-205 Antibodies but Are Not Essential for Subsequent Cytotoxic CD8+ T Cell ResponsesThe Journal of Immunology, 2012
- Technologies for enhanced efficacy of DNA vaccinesExpert Review of Vaccines, 2012
- Targeting Dendritic Cells in vivo for Cancer TherapyFrontiers in Immunology, 2012
- Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvantImmunology, 2010
- Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice against Rift Valley Fever VirusPLoS Neglected Tropical Diseases, 2010
- Bluetongue Virus Targets Conventional Dendritic Cells in Skin LymphJournal of Virology, 2009
- The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cellsJCI Insight, 2008